Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:101-107

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shannon, J. R.
Right arrow Articles by Robertson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shannon, J. R.
Right arrow Articles by Robertson, D.

(Hypertension. 1998;32:101-107.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Uncoupling of the Baroreflex by NN-Cholinergic Blockade in Dissecting the Components of Cardiovascular Regulation

John R. Shannon; Jens Jordan; Bonnie K. Black; Fernando Costa; ; David Robertson

From the Autonomic Dysfunction Center, Vanderbilt University, Nashville, Tenn.

Correspondence to David Robertson, MD, Autonomic Dysfunction Center, AA3228 MCN, Vanderbilt University, Nashville, TN 37232-2195. E-mail david.robertson{at}mcmail.vanderbilt.edu

Abstract—Systemic administration of adrenergic agonists and nitric oxide donors is used extensively to determine cardiovascular receptor sensitivity. Conclusions regarding receptor sensitivity in the presence of the baroreflex may be misleading. In 8 normal volunteers, we determined the heart rate and blood pressure changes after incremental bolus doses of isoproterenol, phenylephrine, and sodium nitroprusside before and during neuronal nicotinic cholinergic (NN-cholinergic) blockade with trimethaphan. Results are given as median (25th/75th percentile). With trimethaphan, the baroreflex slope (as determined by bolus doses of nitroprusside and phenylephrine) decreased from 24 (22/26) to 0.00 (0.00/0.09) ms/mm Hg (P<0.01). The dose of isoproterenol that decreased systolic blood pressure (SBP) 12.5 mm Hg changed from 0.61 (0.51/5.3) to 0.17 (0.12/0.21) µg (P<0.01); the dose required to increase heart rate 12.5 bpm changed from 0.22 (0.17/0.41) to 0.74 (0.33/2.3) µg (P<0.01). The dose of nitroprusside required to decrease SBP 12.5 mm Hg changed from 2.3 (1.3/3.4) to 0.18 (0.14/0.24) µg/kg (P<0.01). The dose of phenylephrine required to increase SBP 12.5 mm Hg changed from 135 (110/200) to 16 (10/30) µg (P<0.01). We conclude that the efferent arc of the baroreflex can be completely interrupted with NN-cholinergic blockade. Estimation of adrenoreceptor sensitivity and sensitivity to nitric oxide donors by systemic administration of agonists is severely confounded by baroreflexes. Uncoupling of the baroreflex by NN-cholinergic blockade may be a useful method to obtain an integrated measure of adrenergic receptor sensitivity and sensitivity to nitric oxide donors in humans. This approach would permit the comparison of normal and abnormal physiological states without the "noise" of baroreflex buffering.


Key Words: receptors, adrenergic • phenylephrine • nitroprusside • isoproterenol • trimethaphan




This article has been cited by other articles:


Home page
HypertensionHome page
I. Moldovanova, C. Schroeder, G. Jacob, C. Hiemke, A. Diedrich, F. C. Luft, and J. Jordan
Hormonal Influences on Cardiovascular Norepinephrine Transporter Responses in Healthy Women
Hypertension, April 1, 2008; 51(4): 1203 - 1209.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Zhang and B. D. Levine
Autonomic Ganglionic Blockade Does Not Prevent Reduction in Cerebral Blood Flow Velocity During Orthostasis in Humans
Stroke, April 1, 2007; 38(4): 1238 - 1244.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. H. Eisenach, D. R. Schroeder, T. L. Pike, C. P. Johnson, W. G. Schrage, E. M. Snyder, B. D. Johnson, V. D. Garovic, S. T. Turner, and M. J. Joyner
Dietary sodium restriction and {beta}2-adrenergic receptor polymorphism modulate cardiovascular function in humans
J. Physiol., August 1, 2006; 574(3): 955 - 965.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. Schroeder, S. Vernino, A. L. Birkenfeld, J. Tank, K. Heusser, A. Lipp, T. Benter, C. Lindschau, R. Kettritz, F. C. Luft, et al.
Plasma exchange for primary autoimmune autonomic failure.
N. Engl. J. Med., October 13, 2005; 353(15): 1585 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. D. Christou, P. Parker Jones, A. E. Pimentel, and D. R. Seals
Increased abdominal-to-peripheral fat distribution contributes to altered autonomic-circulatory control with human aging
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1530 - H1537.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Tank, C. Schroeder, A. Diedrich, E. Szczech, S. Haertter, A. M. Sharma, F. C. Luft, and J. Jordan
Selective Impairment in Sympathetic Vasomotor Control With Norepinephrine Transporter Inhibition
Circulation, June 17, 2003; 107(23): 2949 - 2954.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. D. Christou, P. P. Jones, and D. R. Seals
Baroreflex Buffering in Sedentary and Endurance Exercise-Trained Healthy Men
Hypertension, June 1, 2003; 41(6): 1219 - 1222.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. P. Jones, D. D. Christou, J. Jordan, and D. R. Seals
Baroreflex Buffering Is Reduced With Age in Healthy Men
Circulation, April 8, 2003; 107(13): 1770 - 1774.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. P. Carson, A. Diedrich, and D. Robertson
Autonomic control after blockade of the norepinephrine transporter: a model of orthostatic intolerance
J Appl Physiol, December 1, 2002; 93(6): 2192 - 2198.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Diedrich, J. Jordan, J. R. Shannon, D. Robertson, and I. Biaggioni
Modulation of QT Interval During Autonomic Nervous System Blockade in Humans
Circulation, October 22, 2002; 106(17): 2238 - 2243.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Zhang, J. H. Zuckerman, K. Iwasaki, T. E. Wilson, C. G. Crandall, and B. D. Levine
Autonomic Neural Control of Dynamic Cerebral Autoregulation in Humans
Circulation, October 1, 2002; 106(14): 1814 - 1820.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. Zhang, K. Iwasaki, J. H Zuckerman, K. Behbehani, C. G Crandall, and B. D Levine
Mechanism of blood pressure and R-R variability: insights from ganglion blockade in humans
J. Physiol., August 15, 2002; 543(1): 337 - 348.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Jordan, A. Lipp, J. Tank, C. Schroder, M. Stoffels, G. Franke, A. Diedrich, G. Arnold, D. S. Goldstein, A. M. Sharma, et al.
Catechol-O-Methyltransferase and Blood Pressure in Humans
Circulation, July 23, 2002; 106(4): 460 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Hirshoren, I. Tzoran, I. Makrienko, Y. Edoute, M. M. Plawner, J. Itskovitz-Eldor, and G. Jacob
Menstrual Cycle Effects on the Neurohumoral and Autonomic Nervous Systems Regulating the Cardiovascular System
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1569 - 1575.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Schroeder, J. Tank, M. Boschmann, A. Diedrich, A. M. Sharma, I. Biaggioni, F. C. Luft, and J. Jordan
Selective Norepinephrine Reuptake Inhibition as a Human Model of Orthostatic Intolerance
Circulation, January 22, 2002; 105(3): 347 - 353.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Deschamps, S. B. Backman, V. Novak, G. Plourde, P. Fiset, and D. Chartrand
Effects of the Anticholinesterase Edrophonium on Spectral Analysis of Heart Rate and Blood Pressure Variability in Humans
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 112 - 117.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Jordan, J. R. Shannon, A. Diedrich, B. K. Black, and D. Robertson
Increased Sympathetic Activation in Idiopathic Orthostatic Intolerance: Role of Systemic Adrenoreceptor Sensitivity
Hypertension, January 1, 2002; 39(1): 173 - 178.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Jordan, H. R. Toka, K. Heusser, O. Toka, J. R. Shannon, J. Tank, A. Diedrich, C. Stabroth, M. Stoffels, R. Naraghi, et al.
Severely Impaired Baroreflex-Buffering in Patients With Monogenic Hypertension and Neurovascular Contact
Circulation, November 21, 2000; 102(21): 2611 - 2618.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Jordan, J. R. Shannon, A. Diedrich, B. Black, F. Costa, D. Robertson, and I. Biaggioni
Interaction of Carbon Dioxide and Sympathetic Nervous System Activity in the Regulation of Cerebral Perfusion in Humans
Hypertension, September 1, 2000; 36(3): 383 - 388.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. R. Shannon, J. Jordan, A. Diedrich, B. Pohar, B. K. Black, D. Robertson, and I. Biaggioni
Sympathetically Mediated Hypertension in Autonomic Failure
Circulation, June 13, 2000; 101(23): 2710 - 2715.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. R. Shannon, N. L. Flattem, J. Jordan, G. Jacob, B. K. Black, I. Biaggioni, R. D. Blakely, and D. Robertson
Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency
N. Engl. J. Med., February 24, 2000; 342(8): 541 - 549.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. J. Carvalho, A. H. van den Meiracker, F. Boomsma, J. Freitas, A. J. Man in `t Veld, O. Costa, and A. F. de Freitas
Role of Sympathetic Nervous System in Cyclosporine-Induced Rise in Blood Pressure
Hypertension, July 1, 1999; 34(1): 102 - 106.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Sato, T. Kawada, M. Inagaki, T. Shishido, H. Takaki, M. Sugimachi, and K. Sunagawa
New analytic framework for understanding sympathetic baroreflex control of arterial pressure
Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2251 - H2261.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Gratze, J. Fortin, R. Labugger, A. Binder, P. Kotanko, B. Timmermann, F. C Luft, M. R Hoehe, and F. Skrabal
ß-2 Adrenergic Receptor Variants Affect Resting Blood Pressure and Agonist-Induced Vasodilation in Young Adult Caucasians
Hypertension, June 1, 1999; 33(6): 1425 - 1430.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Jacob, J. R. Shannon, F. Costa, R. Furlan, I. Biaggioni, R. Mosqueda-Garcia, R. M. Robertson, and D. Robertson
Abnormal Norepinephrine Clearance and Adrenergic Receptor Sensitivity in Idiopathic Orthostatic Intolerance
Circulation, April 6, 1999; 99(13): 1706 - 1712.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Jordan, J. Tank, J. R. Shannon, A. Diedrich, A. Lipp, C. Schroder, G. Arnold, A. M. Sharma, I. Biaggioni, D. Robertson, et al.
Baroreflex Buffering and Susceptibility to Vasoactive Drugs
Circulation, March 26, 2002; 105(12): 1459 - 1464.
[Abstract] [Full Text] [PDF]